UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer

Nature communications, 2016-06, Vol.7 (1), p.11883-11883, Article 11883

2016

Volltextzugriff (PDF)

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

Haematologica (Roma), 2019-07, Vol.104 (7), p.1440

2019

Volltextzugriff (PDF)

Mutational Analysis of Ionizing Radiation Induced Neoplasms

Cell reports (Cambridge), 2015-09, Vol.12 (11), p.1915-1926

2015

Volltextzugriff (PDF)

A pooled mutational analysis identifies ionizing radiation-associated mutational signatures conserved between mouse and human malignancies

Scientific reports, 2017-08, Vol.7 (1), p.7645-10, Article 7645

2017

Volltextzugriff (PDF)

Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

Leukemia, 2021-07, Vol.35 (7), p.2043-2053

2021

Volltextzugriff (PDF)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

Leukemia, 2020-11, Vol.34 (11), p.3091-3096

2020

Volltextzugriff (PDF)

Baculum morphology predicts reproductive success of male house mice under sexual selection

BMC biology, 2013-06, Vol.11 (1), p.66-66, Article 66

2013

Volltextzugriff (PDF)

Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia

Proceedings of the National Academy of Sciences - PNAS, 2013-04, Vol.110 (18), p.7429-7433

2013

Volltextzugriff (PDF)

The Genetic Basis of Inbreeding Avoidance in House Mice

Current biology, 2007-12, Vol.17 (23), p.2061-2066

2007

Volltextzugriff (PDF)

Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

Clinical cancer research, 2017-04, Vol.23 (7), p.1852-1861

2017

Volltextzugriff (PDF)

Subclonal TP53 copy number is associated with prognosis in multiple myeloma

Blood, 2018-12, Vol.132 (23), p.2465-2469

2018

Volltextzugriff (PDF)

High-Throughput Molecular Cancer Cell Line Characterization Using Digital Multiplex Ligation-Dependent Probe Amplification for Improved Standardization of in Vitro Research

The Journal of molecular diagnostics : JMD, 2020-09, Vol.22 (9), p.1179-1188

2020

Volltextzugriff (PDF)

The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia

Genes chromosomes & cancer, 2013-10, Vol.52 (10), p.954-960

2013

Volltextzugriff (PDF)

An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics

Blood cancer journal (New York), 2020-10, Vol.10 (10), p.101-101, Article 101

2020

Volltextzugriff (PDF)

Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers

Environmental health, 2018-05, Vol.17 (1), p.43-9, Article 43

2018

Volltextzugriff (PDF)

Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence

Leukemia & lymphoma, 2010-10, Vol.51 (10), p.1870-1874

2010

Volltextzugriff (PDF)

Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes

Familial cancer, 2016-10, Vol.15 (4), p.593-599

2016

Volltextzugriff (PDF)

Role of 657del5 NBN mutation and 7p12.2 ( IKZF1 ), 9p21 ( CDKN2A ), 10q21.2 ( ARID5B ) and 14q11.2 ( CEBPE ) variation and risk of childhood ALL in the Polish population

Leukemia research, 2011-11, Vol.35 (11), p.1534-1536

2011

Volltextzugriff (PDF)

What are genome-wide association studies telling us about B-cell tumor development?

Oncotarget, 2010-09, Vol.1 (5), p.367-372

2010

Volltextzugriff (PDF)

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma

Journal of clinical oncology, 2023-08, Vol.41 (23), p.3945-3955

2023

Volltextzugriff (PDF)

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing

Journal of clinical oncology, 2015-02, Vol.33 (5), p.426-432

2015

Volltextzugriff (PDF)

Turbulence and stratification in Priest Pot, a productive pond in a sheltered environment

Limnology, 2007-08, Vol.8 (2), p.113-120

2007

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(52)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(25)
Humans
(23)
Male
(12)
Female
(11)
Oncology
(10)
Hematology
(9)
Genetic Predisposition To Disease
(8)
Mutation
(8)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics
(8)
Risk Factors
(8)
Case-Control Studies
(6)
Child
(6)
Genetics
(6)
Multiple Myeloma - Genetics
(6)
Adult
(5)
Genetics & Heredity
(5)
Middle Aged
(5)
Polymorphism, Single Nucleotide
(5)
Alleles
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(16)
Nature Genetics
(5)
Clinical Lymphoma, Myeloma And Leukemia
(3)
Cancer Research
(2)
Haematologica
(2)
Journal Of Clinical Oncology
(2)
Leukemia
(2)
Acs Chemical Biology
(1)
Blood Cancer Journal
(1)
Bmc Biology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk

Mutational Analysis of Ionizing Radiation Induced Neoplasms

A pooled mutational analysis identifies ionizing radiation-associated mutational signatures conserved between mouse and human malignancies

Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

Baculum morphology predicts reproductive success of male house mice under sexual selection

Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia

The Genetic Basis of Inbreeding Avoidance in House Mice

Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

Subclonal TP53 copy number is associated with prognosis in multiple myeloma

High-Throughput Molecular Cancer Cell Line Characterization Using Digital Multiplex Ligation-Dependent Probe Amplification for Improved Standardization of in Vitro Research

The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia

An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics

Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers

Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence

Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes

Role of 657del5 NBN mutation and 7p12.2 ( IKZF1 ), 9p21 ( CDKN2A ), 10q21.2 ( ARID5B ) and 14q11.2 ( CEBPE ) variation and risk of childhood ALL in the Polish population

What are genome-wide association studies telling us about B-cell tumor development?

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing

Turbulence and stratification in Priest Pot, a productive pond in a sheltered environment

Suchergebnisse filtern